Author:
Babaei M,Eshghi H,Abnous Kh,Rahimizadeh M,Ramezani M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference41 articles.
1. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669–672.
2. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007; 369: 2097–2105.
3. Yang ZR, Wang HF, Zhao J, Peng YY, Wang J, Guinn BA et al. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther 2007; 14: 599–615.
4. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N et al. Organically modified silica nanoparticles: a non-viral vector for in vivo gene delivery and expression in the brain. P Natl Acad Sci USA 2005; 102: 11539–11544.
5. Kazemi Oskuee R, Zakeri V, Gholami L, Malaekeh-Nikouei B . Preparation, characterization and transfection efficiency of nanoparticles composed of alkane-modified polyallylamine. Nanomed J 2015; 2: 111–120.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献